Media-OutReach Newswire Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
Decision 604/QD-TTg: revised strategy on science, technology and innovation through 2030 approved with ambitious targets (Part 2) 4.